Gustine, J., Attar, N., Puliafito, B., Cirstea, D., Branagan, A., Maus, M., Frigault, M., Yee, A., Raje, N. (2025). Validation and refinement of the new high-risk multiple myeloma (HRMM) criteria in relapsed or refractory patients treated with BCMA CAR-T.. Blood. https://doi.org/10.1182/blood-2025-2243